Replies to post #163538 on Biotech Values

[biomaven0]

>>GLPG1205

You have to give them credit for both a novel target and now a novel drug. But from an investment standpoint, we have nothing much to go on here except the amount of the milestone.

Another shot on goal though, which can't hurt.

Peter